Oruka Therapeutics Inc
F:HQ1
Oruka Therapeutics Inc
F:HQ1
Price:
71.5
EUR
-2.05%
Market Closed
Market Cap:
€3.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Oruka Therapeutics Inc
F:HQ1
|
US |
|
M
|
Mkango Resources Ltd
SWB:ZMK
|
CA |
|
G
|
Graphisoft Park SE Ingatlanfejleszto Europai Rt
F:GUV
|
HU |
|
Henkel AG & Co KGaA
F:HEN3
|
DE |
|
T
|
Trend Micro Inc
SWB:TMI
|
JP |
|
S
|
SCYNEXIS Inc
F:135A
|
US |
|
Shimizu Corp
F:XSZ
|
JP |
|
NACCO Industries Inc
NYSE:NC
|
US |
|
Charter Hall Social Infrastructure REIT
F:B6Z0
|
AU |
|
C
|
Canon Inc
XHAM:CNN1
|
JP |
Wall St Price Targets
HQ1 Price Targets Summary
Oruka Therapeutics Inc
Oruka Therapeutics Inc
Wall Street analysts forecast HQ1 stock price to drop over the next 12 months.
According to Wall Street analysts, the average 1-year price target for HQ1 is 54.64 EUR with a low forecast of 38.29 EUR and a high forecast of 79.61 EUR.
Lowest Forecast
Price Target
38.29
EUR
46% Downside
Average Forecast
Price Target
54.64
EUR
24% Downside
Highest Forecast
Price Target
79.61
EUR
11% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HQ1's stock price target?
Price Target
54.64
EUR
54.64
EUR
According to Wall Street analysts, the average 1-year price target for HQ1 is 54.64 EUR with a low forecast of 38.29 EUR and a high forecast of 79.61 EUR.
